Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives
About this item
Full title
Author / Creator
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Classic Philadelphia-negative myeloproliferative neoplasms (MPN) include polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF), classified as primary (PMF), or secondary to PV or ET. All MPN, regardless of the underlying driver mutation in
JAK2
/
CALR
/
MPL
, are invariably associated with dysregulation of...
Alternative Titles
Full title
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2645469050
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2645469050
Other Identifiers
ISSN
0925-5710
E-ISSN
1865-3774
DOI
10.1007/s12185-022-03335-7
